|
|
 |
|
Viewing report
|
|
|
|
Hormone Replacement Therapy (HRT) - Global Strategic Business Report
Global Industry Analysts, Inc, Sep 2011, Pages: 428
This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets.
The report profiles 42 companies including many key and niche players such as Bayer HealthCare Pharmaceuticals, Inc., Besins Healthcare SA, Hisamitsu Pharmaceutical Co., Inc., Noven Pharmaceuticals, Inc., Mylan Canada, Novartis AG, Novo Nordisk A/S, Orion Corporation, Pfizer, Inc., Wyeth Pharmaceuticals, Inc., Rottapharm SpA, Teva Pharmaceutical Industries Ltd., Théramex, Warner Chilcott, and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
|
|
|
|
